Testosterone/dutasteride
From Wikipedia, the free encyclopedia
Combination drug
| Combination of | |
|---|---|
| Testosterone | Androgen |
| Dutasteride | 5α-Reductase inhibitor |
| Clinical data | |
| Other names | Dutasteride/testosterone |
Testosterone/dutasteride is a combination formulation of testosterone, an androgen, and dutasteride, a 5α-reductase inhibitor, which was under development by GlaxoSmithKline for the treatment of hypogonadism (low testosterone levels) in men in the 2000s.[1] It reached phase II clinical trials prior to the discontinuation of its development.[1]
References
[edit]- ^ a b "Testosterone/dutasteride". AdisInsight. Springer Nature Switzerland AG.
 | This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
Hidden categories:
- Articles with short description
- Short description matches Wikidata
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drugs that are a combination of chemicals
- All stub articles